Results 191 to 200 of about 136,614 (358)

Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers

Gut, 2017
M. Pfefferkorn, S. Böhm, T. Schott, D. Deichsel, C. Bremer, K. Schröder, W. Gerlich, D. Glebe, T. Berg, F. van Bömmel   +9 more
semanticscholar   +1 more source

The Current Burden of Hepatitis B in the United States: A State, Territorial, and County Modelling Analysis

Journal of Viral Hepatitis, Volume 33, Issue 1, January 2026.
ABSTRACT Accurate estimates of the prevalence of chronic hepatitis B virus (HBV) in the United States (US) are necessary for policy makers and community‐based organisations to make informed decisions regarding the allocation of resources to work towards the elimination of HBV as a public health threat.
Devin Razavi‐Shearer, Ivane Gamkrelidze, Samantha Hall, Chari Cohen, Robert Gish, Thaddeus Pham, Kathryn Razavi‐Shearer, William Remak, Myriam Saboui, Alexis Voeller, Carolyn Wallace, Homie Razavi   +11 more
wiley   +1 more source

Impaired trophoblast Toll-Like Receptor 3 signaling pathway involves in hepatitis B vaccine non- or hypo-response of infants born to HBsAg-positive mothers [PDF]

, 2020
Lina Wu, Ruijun Zhang, Yongliang Feng, Tian Yao, Linzhu Yi, Huili Wan, Junli Li, Shuying Feng, Bo Wang, Suping Wang   +9 more
openalex   +1 more source

Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug

HLA, Volume 107, Issue 1, January 2026.
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk, Ilse Gille, Carolt Arana, Jordi Rovira, Eduard Palou, Fritz Diekmann, Dave L. Roelen, Mirjam H. M. Heemskerk, Sebastiaan Heidt   +8 more
wiley   +1 more source

Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage. [PDF]

PLoS One
Shimoda A, Murai K, Hikita H, Minami S, Miyake T, Kuriki S, Sometani E, Sung J, Shigeno S, Higuchi Y, Maesaka K, Shirai K, Tahata Y, Saito Y, Kodama T, Takahashi T, Suemizu H, Takehara T.   +17 more
europepmc   +1 more source

Pyoderma Gangrenosum as the First Manifestation of Inflammatory Bowel Disease: A Case Report

Case Reports in Gastrointestinal Medicine, Volume 2026, Issue 1, 2026.
Approximately 50% of patients with inflammatory bowel disease (IBD) exhibit extraintestinal manifestations, among which skin and mucosal lesions are common. However, pyoderma gangrenosum occurs in only 1%‐2% of IBD patients. We report the case of a 23‐year‐old male patient who was admitted to the hospital with pyoderma gangrenosum that was unresponsive
Nam Hoai Nguyen, Tan Thi Tran, Trang Thu Khuc, Yen Thi Lo, Ha Thi-Ngoc Doan, Hieu Van Nguyen, Long Cong Nguyen, Marcel Cc Machado   +7 more
wiley   +1 more source

Seroprevalence of hepatitis B Surface antigen among apparently healthy primary school pupils inBatagarawa Local Government area of Katsina State, Nigeria

Nigerian Journal of Paediatrics
Introduction: Hepatitis B virus infection is a major public health problem worldwide. It is more infectious and more in Nigeria than the Human Immunodeficiency Virus (HIV).
Habibu B, Belonwu R, Ibrahim M
doaj  

Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-α therapy: correlation with specific IgG subclass responses to HBsAg [PDF]

, 2005
Hanna Gregorek, Katarzyna Dzierżanowska‐Fangrat, Marek Woynarowski, Paulina Jóźwiak, Ewa Witkowska-Vogtt, Jerzy Socha, Małgorzata Syczewska, K Madaliński   +7 more
openalex   +1 more source

Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?

Journal of Clinical Microbiology, 2017
Yuhua Gao, Yutang Li, Q. Meng, Zhan-qing Zhang, P. Zhao, Q. Shang, Yue Li, Ming-ze Su, Tong Li, Xueen Liu, Zhuang Hui   +10 more
semanticscholar   +1 more source

DPMAS in the Management of Severe Acute Liver Injury

Case Reports in Hepatology, Volume 2026, Issue 1, 2026.
Background Acute liver injury is a severe disease in which a hepatic and later systemic inflammatory response is triggered, generally induced by paracetamol intoxication, undetermined causes, drugs, and hepatotropic and nonhepatotropic viruses. Case Summary A 67‐year‐old immunocompetent male with severe acute liver injury secondary to Cytomegalovirus ...
Maiko Alejandro Tavera Díaz, Annia Aguilar Loayza, Carolina Beatriz Mejía Vargas, Juan Fernando Mamani Ochoa, Sreeja Dattachoudhury   +4 more
wiley   +1 more source